Overview
Properties
Constituents: 50% Glycerol, 0.05% Tween 20, 3mM DTT, 25mM Tris HCl, 100mM Sodium chloride, 10mM Reduced glutathione, pH 8
Concentration information loading...Applications
Our Abpromise guarantee covers the use of ab42614 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
| Application | Notes |
|---|---|
| Inhibition Assay |
Not yet tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.
Protein info
-
Alternative names
- CD309CD309 antigenFetal liver kinase 1
- FLK-1FLK1KdrKinase insert domain receptorKinase insert domain receptor (a type III receptor tyrosine kinase)KRD1Ly73Protein tyrosine kinase receptor FLK1Protein-tyrosine kinase receptor flk-1Tyrosine kinase growth factor receptorVascular endothelial growth factor receptor 2VEGFRVEGFR 2VEGFR-2VEGFR2VGFR2_HUMAN
see all
Contains 7 Ig-like C2-type (immunoglobulin-like) domains.
Contains 1 protein kinase domain.
modificationsPhosphorylated. Dephosphorylated by PTPRB. Dephosphorylated by PTPRJ at Tyr-951, Tyr-996, Tyr-1054, Tyr-1059, Tyr-1175 and Tyr-1214.
Target information above from: UniProt accession
P35968
The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010)
.
References for VEGF Receptor 2 protein (Tagged) (ab42614)
ab42614 has not yet been referenced specifically in any publications.